Donanemab
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Donanemab, covering 2023-11-02 to 2026-06-03. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5) [Phase 3]